William Barajimenez, MD
Neurology · Kensington, MDNPI 1407931496
Payments from drug & device makers
Across 1,917 payments — averaging $37.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EMD Serono, Inc.$36K
- AbbVie$5K
- Teva Pharmaceuticals USA, Inc.$3K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Otsuka America Pharmaceutical, Inc.$1K
- UCB, Inc.$1K
- plus $23K from 54 others
What the payments were for
- Speaking & faculty fees$33,98948%
- Travel & lodging$1,4252%
- Food & beverage$34,54348%
- Education$1,4442%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$71,402 in reported general payments places this provider in the 85th percentile of 442 neurology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| WakixPitolisant Hcl | 53 | $778,514 |
| CortrophinCorticotropin | 19 | $696,153 |
| NuplazidPimavanserin Tartrate | 71 | $433,649 |
| CaplytaLumateperone Tosylate | 175 | $289,421 |
| IngrezzaValbenazine Tosylate | 31 | $234,537 |
| Austedo XrDeutetrabenazine | 19 | $206,570 |
| NourianzIstradefylline | 97 | $193,827 |
| TrintellixVortioxetine Hydrobromide | 207 | $119,136 |
| AptiomEslicarbazepine Acetate | 39 | $90,917 |
| Nurtec OdtRimegepant Sulfate | 47 | $89,790 |
| MounjaroTirzepatide | 87 | $88,039 |
| RexultiBrexpiprazole | 40 | $87,327 |
| NeuproRotigotine | 68 | $81,535 |
| SunosiSolriamfetol Hcl | 56 | $60,893 |
| UbrelvyUbrogepant | 43 | $58,006 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Harmony Biosciences LLCWakix | $1,303 | $778,51453 claims |
| Acadia Pharmaceuticals IncNuplazid | $859 | $433,64971 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,898 | $289,421175 claims |
| Neurocrine Biosciences, Inc.Ingrezza, Ongentys | $780 | $263,09471 claims |
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $2,521 | $206,57019 claims |
| Kyowa Kirin, Inc.Nourianz | $973 | $193,82797 claims |
| AbbVieUbrelvy, Qulipta, Vraylar, Fetzima | $4,574 | $156,344137 claims |
| UCB, Inc.Neupro, Briviact | $1,398 | $134,271106 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $418 | $119,136207 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $216 | $90,91739 claims |
| PfizerNurtec Odt | $921 | $89,79047 claims |
| Lilly USA, LLCMounjaro | $1,390 | $88,03987 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 442 neurology providers in Maryland.
Other neurology in Kensington
- Jose MasdeuBethesda$5.8M
- Ellen MowryBaltimore$5.7M
- Daniel BeckerLutherville$4.2M
- Michael PolydefkisBaltimore$4.1M
- Pavel KleinBethesda$3.2M
- Jeffrey RothsteinBaltimore$3M
- Pavan BhargavaBaltimore$2.8M
- Thomas CrawfordBaltimore$2.4M
- Nicholas MaragakisBaltimore$2.2M
- Shiv SaidhaBaltimore$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.